Nurix Therapeutics: Protein Deg Specialist's Latest Data Establishes Bull Case | Old North State Wealth News
Connect with us


Nurix Therapeutics: Protein Deg Specialist’s Latest Data Establishes Bull Case



PM Images

Overview: Nurix and The Protein Deg Field Of Drug Development

San Francisco-based biotech company Nurix Therapeutics (NASDAQ:NRIX) completed its Initial Public Offering (“IPO”) in July 2020, raising ~$209m via the issuance of ~11m shares priced at $11 per share.

Nurix’ area10K submission

Read the full article here


Copyright © 2022 ONSWM News. Content posted on the Old North State Wealth News page was developed and produced by a third party news aggregation service. Old North State Wealth Management is not affiliated with the news aggregation service. The information presented is believed to be current. It should not be viewed as personalized investment advice. All expressions of opinion reflect the judgment of the authors on the date the articles were published. The information presented is not an offer to buy or sell, or a solicitation of any offer to buy or sell, any of the securities discussed.